Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Relx Plc (RELX)

Relx Plc (RELX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,993,564
  • Shares Outstanding, K 1,931,427
  • Annual Sales, $ 10,054 M
  • Annual Income, $ 1,922 M
  • 60-Month Beta 0.53
  • Price/Sales 4.17
  • Price/Cash Flow 13.24
  • Price/Book 16.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.53 +4.27%
on 09/24/20
23.59 -4.83%
on 09/16/20
-0.37 (-1.62%)
since 08/28/20
3-Month
21.02 +6.78%
on 07/31/20
23.68 -5.19%
on 07/01/20
-1.01 (-4.31%)
since 06/26/20
52-Week
16.81 +33.55%
on 03/23/20
27.25 -17.63%
on 02/18/20
-1.29 (-5.43%)
since 09/27/19

Most Recent Stories

More News
Health System Survey Shows Lack of Ownership Over Provider Data as It Highlights its Importance

, /PRNewswire/ -- The Health Care business of  has announced the results of a survey designed to identify provider data governance decision-makers in provider organizations and understand data governance...

RELX : 22.41 (+0.67%)
The LexisNexis Risk Solutions Cybercrime Report Reveals New Opportunities and Risks for EMEA in Online Channels During Global Pandemic

Findings from the first half of 2020 highlight overall decline in human-initiated attacks, growth in bot attacks targeting financial services organizations

RELX : 22.41 (+0.67%)
The LexisNexis Risk Solutions Cybercrime Report Reveals New Opportunities and Risks for the U.S. and Canada in Digital Channels During Global Pandemic

, /PRNewswire/ -- LexisNexis Risk Solutions today released its biannual Cybercrime Report, which tracks global cybercrime activity from January through . The report dives deep into how the COVID-19 pandemic...

RELX : 22.41 (+0.67%)
LexisNexis Risk Solutions Study Illustrates How Auto Insurers Can More Effectively Engage with Their Policyholders

, /PRNewswire/ -- , a leading provider of data, analytics and technology for the insurance industry, released the findings of its latest U.S. consumer auto insurance shopping study, providing key insights...

RELX : 22.41 (+0.67%)
Healthcare Industry Veteran to Lead Strategy, Innovation for the Healthcare Business of LexisNexis Risk Solutions

, Aug. 24, 2020 /PRNewswire/ -- The Healthcare business of LexisNexis Risk Solutions announced today that has joined the organization as vice president of strategy.  Reporting directly to the Healthcare...

RELX : 22.41 (+0.67%)
U.S. Auto Insurance Shopping Rebounds after an Unprecedented Drop, According to Insurance Demand Meter from LexisNexis Risk Solutions

, /PRNewswire/ -- released its Latest Insurance Demand Meter, which reports Q2 U.S. auto insurance shopping activity. According to the Meter, auto insurance shopping and new business growth rebounded...

RELX : 22.41 (+0.67%)
The Health Care Business of LexisNexis Risk Solutions Bolsters Marketing Leadership to Support Growth Strategy

, /PRNewswire/ -- The Health Care business of LexisNexis Risk Solutions announced that is joining its leadership team to lead the marketing activities for the organization. Garlitz will report to ,...

RELX : 22.41 (+0.67%)
John Lepore Joins Moderna as Senior Vice President, Government Engagement

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that...

MRNA : 70.39 (+1.32%)
MA : 339.18 (+2.23%)
RELX : 22.41 (+0.67%)
GSK : 37.85 (+0.13%)
LexisNexis Risk Solutions Joins Patient ID Coalition in Support of a National Unique Patient Identifier

, /PRNewswire/ --  has joined coalition to support accurate patient identification and ensure that patients are accurately matched to their health information across care settings and platforms.

RELX : 22.41 (+0.67%)
LexisNexis® Risk Solutions Releases U.S. Auto Insurance Trends Report

, /PRNewswire/ -- introduces its U.S. Auto Insurance Trends Report, which aggregates annual market data about auto insurance shopping, underwriting and claims. The report explores how technology is increasingly...

RELX : 22.41 (+0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade RELX with:

Business Summary

Relx PLC is engaged in providing information solutions. Its products and services comprise intellectual property content delivered through various media, including online, journals and books. The Company's operating segments consists of Scientific, Technical & Medical, Risk & Business Information; Legal...

See More

Key Turning Points

2nd Resistance Point 22.67
1st Resistance Point 22.46
Last Price 22.41
1st Support Level 21.91
2nd Support Level 21.56

See More

52-Week High 27.25
Fibonacci 61.8% 23.27
Last Price 22.41
Fibonacci 50% 22.03
Fibonacci 38.2% 20.80
52-Week Low 16.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar